The GOP tax law is padding health care companies’ bottom lines, according to my colleague Bob Herman’s analysis of newly released financial information from the last quarter of 2018. Overall, the industry’s profits were up significantly from the same period a year earlier.
The big picture: The law made it easier to bring home money that was parked abroad. It also eliminated tax provisions that have specifically helped large companies like Blue Cross Blue Shield insurers. But the lower corporate tax rate is the main event.
- Drug giant Pfizer received a $563 million tax benefit in the fourth quarter, and its corporate income tax rate in all of 2018 was just 6%.
- Johnson & Johnson’s effective tax rate in the last quarter of 2018 was 2.6%.
- Almost half of the $551 million tax break recorded by hospital chain HCA Healthcare in 2018 came in the fourth quarter.
Between the lines: The tax law aside, the companies that handle the most revenue — like health insurers collecting premiums or drug distributors shipping products — are not the most profitable.
- The highest margins still usually belong to pharmaceutical companies and medical-devices.